Evidence map›Paper›PMID 31713186›Full record

ArticleMolecular diversity2020

Antiproliferative activity and apoptosis induction, of organo-antimony(III)-copper(I) conjugates, against human breast cancer cells.

C N Banti, V Tsiatouras, K Karanicolas, N Panagiotou, A J Tasiopoulos, N Kourkoumelis, S K Hadjikakou

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Conjugation of triphenylantimony(V) with carvacrol against human breast cancer cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

C N BantiSection of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. cbanti@uoi.gr.
V TsiatourasSection of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece.
K KaranicolasSection of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece.
N PanagiotouDepartment of Chemistry, University of Cyprus, 1678, Nicosia, Cyprus.
A J TasiopoulosDepartment of Chemistry, University of Cyprus, 1678, Nicosia, Cyprus.
N KourkoumelisMedical Physics Laboratory, Medical School, University of Ioannina, Ioannina, Greece. nkourkou@uoi.gr.
S K HadjikakouSection of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. shadjika@uoi.gr.ORCID http://orcid.org/0000-0001-9556-6266
University of Ioannina · GRUniversity of Cyprus · CY

Funding

Operational Program Competitiveness, Entrepreneurship T1EDK-02990
6 · The paper itself

Abstract

Three known organo-antimony(III)-copper(I), mixed-metal small bioactive molecules (SBAMs) of formula [Cu(tpSb)

Indexed as

AntimonyAntineoplastic AgentsApoptosisBreast NeoplasmsCell Cycle CheckpointsCell DeathCell LineCell Line, TumorCell ProliferationCopperFemaleFibroblastsHumansMCF-7 CellsAntimonyAntineoplastic AgentsCopperBreast cancerCopper(I)–antimony(III) complexesCytotoxic activityMetal biologyMetallotherapeutics

Identifiers

PMID31713186
OpenAlexW2988674721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.